CoChat

Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis

Taillé, Camille, Grootenboer-Mignot, Sabine, Boursier, Céline, Michel, Laurence, Debray, Marie-Pierre, Fagart, Jérôme, Barrientos, Lorena, Mailleux, Arnaud, Cigna, Natacha, Tubach, Florence, Marchal-Sommé, Joëlle, Soler, Paul, Chollet-Martin, Sylvie, Crestani, Bruno · 2011 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Rationale: Injury to alveolar epithelial cells is central to the pathophysiology of idiopathic pulmonary fibrosis (IPF). An abnormal autoimmune response directed against antigens of the alveolar epithelium may contribute to the disease. Objectives: To detect circulating autoantibodies (autoAbs) directed against epithelial structures. Methods: We performed immunoblot by separating human placental amnion extract or alveolar epithelial cell (A549 cell line) proteins on polyacrylamide gels, blotting on nitrocellulose membranes, and incubating with serum from patients with IPF (n = 40) or healthy subjects (n = 40). Proteomic analysis and mass spectrometry characterized the target protein. Inhibition experiments performed with the correspondent recombinant protein confirmed our results. Measurements and Main Results: We identified IgG autoAbs recognizing a 200-kD protein in the serum of patients with IPF. Proteomic analysis identified this protein as human periplakin (PPL), a component of desmosomes. Anti-PPL Abs were found by immunoblot in both serum and bronchoalveolar lavage in patients with IPF: 16/40 (40%) of them were positive versus none of the control subjects. Immunohistochemistry revealed that PPL was strongly expressed in bronchial and alveolar epithelium, but that PPL exhibited changes in intracellular localization among normal and fibrotic alveolar epithelium. In an alveolar epithelial wound repair assay, an anti-PPL IgG decreased cell migration. Recombinant PPL induced bronchoalveolar lavage T lymphocyte proliferation. Patients with IPF with anti-PPL Abs had a more severe respiratory disease, despite no difference in survival. Conclusions: We found a new circulating autoAb directed against PPL in patients with IPF, associated with a more severe disease.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201001-0076oc

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 38

  1. 2001, N Engl J Med, 517
  2. 2007, Am J Respir Crit Care Med, 1007
  3. 2006, J Immunol, 5735
  4. 2007, J Immunol, 2592
  5. 1994, Thorax, 218
  6. 1994, Thorax, 1139
  7. 2002, Clin Exp Immunol, 169
  8. 1998, Thorax, 969
  9. 1999, Lung, 311
  10. 2007, J Cell Mol Med, 462
  11. 2003, Br J Dermatol, 939
  12. 2010, Br J Dermatol, 743
  13. 2009, Am J Respir Crit Care Med, A2176
  14. 2000, Am J Respir Crit Care Med, 646
  15. 1997, AJR Am J Roentgenol, 977
  16. 2004, J Biol Chem, 22773
  17. 2004, Am J Physiol Lung Cell Mol Physiol, L448
  18. 1980, Cell Immunol, 205
  19. 1997, J Cell Biol, 1835
  20. 2002, Exp Dermatol, 428
  21. 1998, J Invest Dermatol, 1236
  22. 1990, N Engl J Med, 1729
  23. 1998, J Clin Invest, 775
  24. 1998, J Invest Dermatol, 503
  25. 2009, Chin Med J (Engl), 486
  26. 2009, Clin Chim Acta, 13
  27. 2004, Br J Dermatol, 1018
  28. 1999, N Engl J Med, 1406
  29. 2002, J Cell Sci, 5027
  30. 2006, J Cell Sci, 5147
  31. 2002, J Cell Sci, 3957
  32. 2004, Proc Natl Acad Sci USA, 10392
  33. 2001, J Invest Dermatol, 556
  34. 2008, J Immunol, 756
  35. 2000, Respiration, 397
  36. 1993, Chest, 1051
  37. 1995, Proc Natl Acad Sci USA, 5239
  38. 2000, Br J Dermatol, 349

Cited by

See all 123

Metadata

Authors
Taillé, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M.-P., Fagart, J., Barrientos, L., Mailleux, A., Cigna, N., Tubach, F., Marchal-Sommé, J., Soler, P., Chollet-Martin, S., & Crestani, B.
Affiliations
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Laboratoire d'Immunologie “Autoimmunité et Hypersensibilités,”
  • Université Paris-Sud (FR)
  • Hôpital Saint-Louis (FR)
  • Service de Radiologie
  • Inserm (FR)
  • Unité 700 and
  • Service de Pneumologie et Centre de Compétence des Maladies Pulmonaires Rares
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2011-03
Volume
183
Issue
6
Pages
759-766
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2105937700
Cited by
120
References
38
Citations by year
2026: 8 · 2025: 6 · 2024: 2 · 2023: 7 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 13 · 2012: 10
FWCI
7.44
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
Keywords
idiopathic pulmonary fibrosis, periplakin, autoantibodies, autoimmunity, alveolar epithelial cells, desmosomes, bronchoalveolar lavage, disease severity, T cell proliferation, epithelial wound repair, cell migration
MeSH terms
Adult, Aged, Autoantibodies, Female, Humans, Immunoglobulin G, Male, Middle Aged, Severity of Illness Index, Biomarkers, Autoimmunity, Case-Control Studies, Respiratory Mucosa, Plakins, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201001-0076oc
The paper
Taillé, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M.-P., Fagart, J., Barrientos, L., Mailleux, A., Cigna, N., Tubach, F., Marchal-Sommé, J., Soler, P., Chollet-Martin, S., & Crestani, B. (2011). Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201001-0076oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.